期刊文献+

血清RhoA与2型糖尿病及其血管并发症的相关性研究 被引量:1

The relationship between RhoA and type 2 diabetes mellitus and its angiopathy
原文传递
导出
摘要 目的探讨RhoA与2型糖尿病(T2DM)及其血管并发症之间的关系。方法入选研究对象160例,其中对照组40例,单纯2型糖尿病组40例,2型糖尿病血管并发症组80例。应用酶联免疫吸附试验(ELISA)测定其RhoA浓度,同时检测血糖、血脂、胰岛素、糖化血红蛋白(HbAlc)等指标水平。结果单纯2型糖尿病组患者血清RhoA水平为(9.91±3.41)ng/ml,明显高于对照组[(4.77±1.92)ng/m1];2型糖尿病血管并发症组患者RhoA水平为(21.27±7.00)ng/ml,明显高于对照组和单纯2型糖尿病组(P均〈0.05)。Logistic回归分析结果显示,RhoA、糖尿病家族史、体重指数、三酰甘油、总胆固醇及低密度脂蛋白胆固醇是2型糖尿病的独立危险因素,RhoA、年龄、吸烟史、HbAlc、总胆固醇及低密度脂蛋白胆固醇是2型糖尿病血管并发症的独立危险因素。结论血清RhoA升高有可能成为预测糖尿病及其血管并发症发生风险的指标之一。 Objective To investigate the association between RhoA and type 2 diabetes mellitus (T2DM)and its angiopathy. Methods The normal control group(group A,n =40) ,the T2DM group ( group B, n = 40 ) and the type 2 diabetic angiopathy group ( group C, n = 80 ) were selected. Fasting plas- ma RhoA, blood glucose, blood lipids, insulin and glycosylated hemoglobin ( HbAlc ) were detected. Results The serum level of RhoA in group B was (9.91 + 3.41 )ng/ml and markedly higher than(4.77 + 1.92)ng/ml in group A. The RhoA in group C was(21.27 +-7.00)ng/ml and significantly higher than that in the group A and B ( all P 〈 0.05 ). Logistic analysis showed that RhoA, diabetic family history, body mass index, triglyceride, total cholesterol ( TC), low-density lipoprotein cholesterol (LDL-C) were the inde- pendent risk factors for T2DM. RhoA, age, smoking history, HbA1 c,TC, LDL-C were the independent risk factors for T2DM vascular complications. Conclusion High serum level of RhoA may be a predictive fac- tor of the risk of T2DM and its vascular complications.
出处 《临床内科杂志》 CAS 2013年第8期546-548,共3页 Journal of Clinical Internal Medicine
关键词 RHOA 2型糖尿病 大血管并发症 微血管并发症 RhoA Type 2 diabetes mellitus Macroangiopathy Microangiopathy
  • 相关文献

参考文献2

二级参考文献42

  • 1郭晓华,黄巧冰,陈波,王述昀,侯凡凡,富宁.晚期糖化终产物诱导内皮细胞通透性增高[J].生理学报,2005,57(2):205-210. 被引量:13
  • 2韩雅玲,于海波,闫承慧,孟子敏,张效林,康建,李少华,王士雯.血清反应因子参与RhoA诱导的人血管内皮细胞肌动蛋白骨架重构[J].生理学报,2005,57(3):295-302. 被引量:8
  • 3李强,郭晓华,朱艳军,陈波,邓建新,黄绪亮,黄巧冰.晚期糖基化终产物诱导内皮细胞紧密连接改变及其机制[J].中国动脉硬化杂志,2006,14(6):499-502. 被引量:9
  • 4Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 2003; 39 (4-5): 187-199.
  • 5Sakabe M, lkeda K, Nakatani K, Kawada N, Imanaka-Yoshida K, Yoshida T, Yamagishi T, Nakajima Y. Rho kinases regulate endothelial invasion and migration during valvuloseptal en- docardial cushion tissue formation. Dev Dyn 2006; 235(1): 94- 104.
  • 6Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001; 91 (4): 1487- 1500.
  • 7Hou FF, Boyce J, Chertow GM, Kay J, Owen WF Jr. Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin. J Am Soc Nephrol 1998; 9 (2): 277-283.
  • 8Iwasaki K, Hayashi K, Fujioka T, Sobue K. Rho/Rho-associated kinase signal regulates myogenic differentiation via myocardin-related transcription factor-A/Smad-dependent transcription of the Id3 gene. J Biol Chem 2008; 283(30): 21230-21241.
  • 9Leto G, Pricci F, Amadio L, Iacobini C, Cordone S, Diaz- Horta O, Romeo G, Barsotti P, Rotella CM, di Mario U, Pugliese G. Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation. Diabetes Metab Res Rev 2001; 17(6): 448-458.
  • 10Enomoto M, Adachi H, Yamagishi S, Takeuchi M, Furuki K, Hino A, Hiratsuka A, Takajo Y, Imaizumi T. Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans. Metabolism 2006; 55 (7): 912-917.

共引文献16

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部